Wit FW - Search Results

1

Nelfinavir plasma concentrations are low during pregnancy.

Nellen JF, Schillevoort I, Wit FW, Bergshoeff AS, Godfried MH, Boer K, Lange JM, Burger DM, Prins JM. Nellen JF, et al. Among authors: wit fw. Clin Infect Dis. 2004 Sep 1;39(5):736-40. doi: 10.1086/422719. Epub 2004 Aug 16. Clin Infect Dis. 2004. PMID: 15356791

2

Improved long-term suppression of HIV-1 replication with a triple-class multidrug regimen compared with standard of care antiretroviral therapy.

van Praag RM, Wit FW, Jurriaans S, de Wolf F, Prins JM, Lange JM. van Praag RM, et al. Among authors: wit fw. AIDS. 2002 Mar 29;16(5):719-25. doi: 10.1097/00002030-200203290-00007. AIDS. 2002. PMID: 11964528

3

Discordant responses during antiretroviral therapy: role of immune activation and T cell redistribution rather than true CD4 T cell loss.

Hazenberg MD, Otto SA, Wit FW, Lange JM, Hamann D, Miedema F. Hazenberg MD, et al. Among authors: wit fw. AIDS. 2002 Jun 14;16(9):1287-9. doi: 10.1097/00002030-200206140-00013. AIDS. 2002. PMID: 12045496 Clinical Trial.

4

Incidence of and risk factors for severe hepatotoxicity associated with antiretroviral combination therapy.

Wit FW, Weverling GJ, Weel J, Jurriaans S, Lange JM. Wit FW, et al. J Infect Dis. 2002 Jul 1;186(1):23-31. doi: 10.1086/341084. Epub 2002 Jun 14. J Infect Dis. 2002. PMID: 12089658

5

CC chemokine receptor 5 delta32 and CC chemokine receptor 2 64I polymorphisms do not influence the virologic and immunologic response to antiretroviral combination therapy in human immunodeficiency virus type 1-infected patients.

Wit FW, van Rij RP, Weverling GJ, Lange JM, Schuitemaker H. Wit FW, et al. J Infect Dis. 2002 Dec 15;186(12):1726-32. doi: 10.1086/345677. Epub 2002 Nov 22. J Infect Dis. 2002. PMID: 12447757

6

Safety of long-term interruption of successful antiretroviral therapy: the ATHENA cohort study.

Wit FW, Blanckenberg DH, Brinkman K, Prins JM, van der Ende ME, Schneider MM, Mulder JW, de Wolf F, Lange JM; ATHENA Study Group. Wit FW, et al. AIDS. 2005 Feb 18;19(3):345-8. AIDS. 2005. PMID: 15718848

7

Plasma HIV-1 RNA decline within the first two weeks of treatment is comparable for nevirapine, efavirenz, or both drugs combined and is not predictive of long-term virologic efficacy: A 2NN substudy.

van Leth F, Huisamen CB, Badaro R, Vandercam B, de Wet J, Montaner JS, Hall DB, Wit FW, Lange JM; 2NN Study Group. van Leth F, et al. Among authors: wit fw. J Acquir Immune Defic Syndr. 2005 Mar 1;38(3):296-300. J Acquir Immune Defic Syndr. 2005. PMID: 15735447 Clinical Trial.

8

Interindividual variability of once-daily ritonavir boosted saquinavir pharmacokinetics in Thai and UK patients.

Autar RS, Boffito M, Hassink E, Wit FW, Ananworanich J, Siangphoe U, Pozniak A, Cooper DA, Phanuphak P, Lange JM, Ruxrungtham K, Burger DM. Autar RS, et al. Among authors: wit fw. J Antimicrob Chemother. 2005 Nov;56(5):908-13. doi: 10.1093/jac/dki354. Epub 2005 Oct 4. J Antimicrob Chemother. 2005. PMID: 16204340 Clinical Trial.

9

Nevirapine plasma concentrations and concomitant use of rifampin in patients coinfected with HIV-1 and tuberculosis.

Autar RS, Wit FW, Sankote J, Mahanontharit A, Anekthananon T, Mootsikapun P, Sujaikaew K, Cooper DA, Lange JM, Phanuphak P, Ruxrungtham K, Burger DM. Autar RS, et al. Among authors: wit fw. Antivir Ther. 2005;10(8):937-43. Antivir Ther. 2005. PMID: 16430199

10

Efavirenz: a review.

Vrouenraets SM, Wit FW, van Tongeren J, Lange JM. Vrouenraets SM, et al. Among authors: wit fw. Expert Opin Pharmacother. 2007 Apr;8(6):851-71. doi: 10.1517/14656566.8.6.851. Expert Opin Pharmacother. 2007. PMID: 17425480 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

236 results

Search Page

Filters